Hyloris Pharmaceuticals S.A.

HYL.BR · BRU
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Operating Activities
Net Income-€2-€2-€1-€1
Dep. & Amort.€0€0€0€0
Deferred Tax€0€0€0€0
Stock-Based Comp.€0€0€0€0
Change in WC€0€0-€0-€0
Other Non-Cash-€0-€0-€1-€1
Operating Cash Flow-€2-€2-€2-€2
Investing Activities
PP&E Inv.€0€0-€0-€0
Net Acquisitions€0€0€0€0
Inv. Purchases€0€0€0€0
Inv. Sales/Matur.€0€0€0€0
Other Inv. Act.-€1-€1-€0-€0
Investing Cash Flow-€1-€1-€0-€0
Financing Activities
Debt Repay.€0€0€0€0
Stock Issued€0€0€0€0
Stock Repurch.€0€0€0€0
Dividends Paid€0€0€0€0
Other Fin. Act.-€0-€0-€0-€0
Financing Cash Flow-€0-€0-€0-€0
Forex Effect-€0-€0€0€0
Net Chg. in Cash€0€0€0€0
Supplemental Information
Beg. Cash€0€0€0€0
End Cash€0€0€0€0
Free Cash Flow-€2-€2-€2-€2
Hyloris Pharmaceuticals S.A. (HYL.BR) Financial Statements & Key Stats | AlphaPilot